Preston Klassen
2013 - Orexigen Therapeutics
In 2013, Preston Klassen earned a total compensation of $1.6M as Executive Vice President, Global Product Development at Orexigen Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,600 |
|---|---|
| Option Awards | $1,049,874 |
| Salary | $370,000 |
| Other | $180 |
| Total | $1,634,654 |
Klassen received $1M in option awards, accounting for 64% of the total pay in 2013.
Klassen also received $214.6K in non-equity incentive plan, $370K in salary and $180 in other compensation.
Rankings
In 2013, Preston Klassen's compensation ranked 4,598th out of 12,286 executives tracked by ExecPay. In other words, Klassen earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,598 out of 12,286 | 63rd |
Division Manufacturing | 1,572 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 455 out of 1,466 | 69th |
Industry group Drugs | 317 out of 1,160 | 73rd |
Industry Pharmaceutical Preparations | 255 out of 890 | 71st |
Source: SEC filing on May 27, 2016.
Klassen's colleagues
We found four more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2013.